HTFL
insider transactionsHeartflow, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-2.1M
0 buy · 2.1M sell
Net value · 90d
-$62.7M
$0 in · $62.7M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
9
0 buy · 2.1M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Grant·A
Director
$515.2K
16.1K sh · $32.05
Own New
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
10.0K sh
Own +16%
-
Exercise·M
Chief Medical Officer · 10b5-1
$22.2K
10.0K sh · $2.22
Own +13%
-
Sell·S
Chief Executive Officer · 10b5-1
$643.0K
22.6K sh · $28.50
Own -4%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
9.2K sh
Own +10%
-
Sell·S
Chief Medical Officer · 10b5-1
$261.3K
9.2K sh · $28.34
Own -10%
-
Exercise·M
Chief Medical Officer · 10b5-1
$175.2K
9.2K sh · $19.00
Own +12%
-
Sell·S
Chief Executive Officer · 10b5-1
$657.0K
22.6K sh · $29.12
Own -4%
-
Other·F
Chief Accounting Officer
$2.5K
82 sh · $29.98
Own -0%
-
Other·F
Chief Medical Officer
$19.1K
637 sh · $29.98
Own -1%
-
Other·F
Vikram Verghese KEY
Chief Financial Officer
$14.2K
473 sh · $29.98
Own -0%
-
Other·F
Chief Executive Officer
$57.1K
1.9K sh · $29.98
Own -0%
-
Other·F
Chief Accounting Officer
$14.7K
485 sh · $30.29
Own -2%
-
Other·F
Chief Medical Officer
$49.5K
1.6K sh · $30.29
Own -2%
-
Other·F
Vikram Verghese KEY
Chief Financial Officer
$46.5K
1.5K sh · $30.29
Own -1%
-
Other·F
Chief Executive Officer
$160.5K
5.3K sh · $30.29
Own -1%
-
Sell·S
-
Sell·S
-
Sell·S
-
Sell·S
-
Sell·S
Chief Executive Officer · 10b5-1
$602.9K
22.6K sh · $26.72
Own -4%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
40.8K sh
Own +100%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
19.1K sh
Own +19%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
291 sh
Own +10%
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
6.8K sh
Own New
-
Sell·S
Chief Medical Officer · 10b5-1
$1.6M
64.5K sh · $24.64
Own -44%
-
Exercise·M
Chief Medical Officer · 10b5-1
$15.2K
6.8K sh · $2.22
Own +5%
-
Exercise·M
Chief Medical Officer · 10b5-1
$90.5K
40.8K sh · $2.22
Own +42%
-
Exercise·M
Chief Medical Officer · 10b5-1
$42.4K
19.1K sh · $2.22
Own +24%
-
Exercise·M
Chief Medical Officer · 10b5-1
$2.4K
291 sh · $8.33
Own +0%
-
Other·J
Director
$0
206.3K sh
-
Other·J
HealthCor Partners Management LP
Director
—
4.6M sh
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | William C Weldon | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Jeffrey C Lightcap | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Wayne Joseph Riley | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Casey M Tansey | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Julie A Cullivan | Grant A | 16.1K | $515.2K |
| Jun 16, 2026 | Timothy C Barabe | Grant A | 16.1K | $515.2K |
| Jun 15, 2026 | Campbell Rogers 10b5-1 | Exercise M | 10.0K | $0 |
| Jun 15, 2026 | Campbell Rogers 10b5-1 | Exercise M | 10.0K | $22.2K |
| Jun 10, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 22.6K | $643.0K |
| May 18, 2026 | Campbell Rogers 10b5-1 | Exercise M | 9.2K | $0 |
| May 18, 2026 | Campbell Rogers 10b5-1 | Sell S | 9.2K | $261.3K |
| May 18, 2026 | Campbell Rogers 10b5-1 | Exercise M | 9.2K | $175.2K |
| May 11, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 22.6K | $657.0K |
| May 7, 2026 | Marie L. Jones | Other F | 82 | $2.5K |
| May 7, 2026 | Campbell Rogers | Other F | 637 | $19.1K |
| May 7, 2026 | Vikram Verghese KEY | Other F | 473 | $14.2K |
| May 7, 2026 | John C.M. Farquhar KEY | Other F | 1.9K | $57.1K |
| May 6, 2026 | Marie L. Jones | Other F | 485 | $14.7K |
| May 6, 2026 | Campbell Rogers | Other F | 1.6K | $49.5K |
| May 6, 2026 | Vikram Verghese KEY | Other F | 1.5K | $46.5K |
| May 6, 2026 | John C.M. Farquhar KEY | Other F | 5.3K | $160.5K |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 56.2K | $1.7M |
| Apr 30, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 892.5K | $26.0M |
| Apr 29, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 797.1K | $23.4M |
| Apr 28, 2026 | Bain Capital Life Sciences Investors, LLC / Bain Capital Life Sciences III General Partner, LLC / Bain Capital Life Sciences Fund III, L.P. / BCLS Fund III Investments GP, LLC / BCLS Fund III Investments, LP | Sell S | 254.1K | $7.8M |
| Apr 10, 2026 | John C.M. Farquhar KEY 10b5-1 | Sell S | 22.6K | $602.9K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 40.8K | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.1K | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 291 | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 6.8K | $0 |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Sell S | 64.5K | $1.6M |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 6.8K | $15.2K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 40.8K | $90.5K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 19.1K | $42.4K |
| Apr 1, 2026 | Campbell Rogers 10b5-1 | Exercise M | 291 | $2.4K |
| Mar 24, 2026 | Jeffrey C Lightcap | Other J | 206.3K | $0 |
| Mar 24, 2026 | HealthCor Partners Management LP | Other J | 4.6M | — |
About HTFL insider trading
This page tracks insider transactions for Heartflow, Inc. (HTFL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.